BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29552756)

  • 1. Correlation between miR-21 and miR-145 and the incidence and prognosis of colorectal cancer.
    Liu Q; Yang W; Luo Y; Hu S; Zhu L
    J BUON; 2018; 23(1):29-35. PubMed ID: 29552756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
    Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
    Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY; Zheng YB; Liu J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of microRNA-100 and its relation with prognosis of colorectal cancer].
    Zhang S; Yuan W; Tang W; Xu C; Ma J
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):603-8. PubMed ID: 26714601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
    Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
    Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Li ZW; Yang YM; Du LT; Dong Z; Wang LL; Zhang X; Zhou XJ; Zheng GX; Qu AL; Wang CX
    Med Oncol; 2014 Nov; 31(11):256. PubMed ID: 25270282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer.
    Li G; Wang Q; Li Z; Shen Y
    Rev Esp Enferm Dig; 2020 Nov; 112(11):832-837. PubMed ID: 33054296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.
    Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H
    Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.